catechin has been researched along with Carcinoma, Ehrlich Tumor in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (13.33) | 18.7374 |
| 1990's | 3 (20.00) | 18.2507 |
| 2000's | 4 (26.67) | 29.6817 |
| 2010's | 5 (33.33) | 24.3611 |
| 2020's | 1 (6.67) | 2.80 |
| Authors | Studies |
|---|---|
| Araujo, AADC; Azambuja Ribeiro, RIM; Do Carmo, LF; Frazao Lima, GF; Gomes, INF; Longatti, TR; Santos, HBD; Silva, AG; Tome, RG; Villar, JAFP | 1 |
| Bobinski, F; Buffon, LD; da Silva, GS; da Silva, TBGC; David, IMB; de Souza Fernandes, F; Dos Santos Silva Ferreira, JB; Kopper, MBR; Kviecinski, MR; Lüdtke, DD; Martins, DF; Pedrosa, RC; Zeferino, RC | 1 |
| Jagani, HV; Jain, P; Josyula, VR; Kumar, N; Mallikarjuna Rao, C; Udupa, N; Vasanth Raj, P | 1 |
| Bhatnagar, P; Gupta, KC; Kumar, P; Mishra, S; Shukla, Y; Singh, M | 1 |
| Al-Gayyar, MM; Darweish, MM; El-Mesery, ME; El-Mowafy, AM; Salem, HA | 1 |
| Gupta, KC; Kumar, P; Ray, L | 1 |
| Kurita, T; Miyagishima, A; Nozawa, Y; Sadzuka, Y; Sonobe, T | 1 |
| Hu, JL; Qi, CQ; Su, J; Xue, YC; Zhen, YS | 1 |
| Han, C | 1 |
| Hasuma, T; Kennedy, DO; Matsui-Yuasa, I; Nishimura, S; Otani, S; Yano, Y | 1 |
| Sadzuka, Y; Sonobe, T; Sugiyama, T | 1 |
| Hasuma, T; Kojima, A; Matsui-Yuasa, I; Opare Kennedy, D; Otani, S; Yano, Y | 1 |
| Hasuma, T; Kennedy, DO; Kojima, A; Matsui-Yuasa, I; Moffatt, J; Otani, S; Yamagiwa, H; Yano, Y | 1 |
| Fritz-Niggli, H; Rao, KR | 1 |
| Ehle, H; Ring, K; Schwarz, M | 1 |
15 other study(ies) available for catechin and Carcinoma, Ehrlich Tumor
| Article | Year |
|---|---|
Alkaloid and phenolic compounds of Xylopia aromatica inhibits tumor growth by down-regulating matrix metalloproteinase-2 (MMP-2) expression.
Topics: Alkaloids; Animals; Aporphines; Carcinoma, Ehrlich Tumor; Catechin; Cell Line, Tumor; Cell Proliferation; Chlorogenic Acid; Chromatography, High Pressure Liquid; Down-Regulation; Flavonoids; Gallic Acid; Lymphocytes, Tumor-Infiltrating; Matrix Metalloproteinase 2; Mice; Necrosis; Phenols; Plant Extracts; Plant Leaves; Quercetin; Rutin; Tumor Burden; Xylopia | 2021 |
Dietary supplementation with procyanidin-rich Pinus pinaster extract is associated with attenuated Ehrlich tumor development in mice.
Topics: Animals; Biflavonoids; Carcinoma, Ehrlich Tumor; Catechin; Dietary Supplements; Disease Models, Animal; Male; Mice; Mice, Inbred BALB C; Pinus; Plant Extracts; Proanthocyanidins | 2019 |
A study on the role of (+)-catechin in suppression of HepG2 proliferation via caspase dependent pathway and enhancement of its in vitro and in vivo cytotoxic potential through liposomal formulation.
Topics: Animals; Antineoplastic Agents; bcl-2-Associated X Protein; Carcinoma, Ehrlich Tumor; Caspase 3; Caspase 9; Catechin; Cell Proliferation; Cell Survival; Chemistry, Pharmaceutical; Cytochromes c; Hep G2 Cells; Humans; Liposomes; Mice; Proto-Oncogene Proteins c-bcl-2; Tumor Suppressor Protein p53 | 2013 |
PLGA-encapsulated tea polyphenols enhance the chemotherapeutic efficacy of cisplatin against human cancer cells and mice bearing Ehrlich ascites carcinoma.
Topics: Animals; Antineoplastic Agents; Antioxidants; Apoptosis; Biflavonoids; Carcinoma, Ehrlich Tumor; Catechin; Cell Count; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cisplatin; Female; Flow Cytometry; Humans; Kinetics; Lactic Acid; Mice; Mitochondria; Nanoparticles; Neovascularization, Pathologic; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polyphenols; Reactive Oxygen Species; Tea | 2015 |
Novel chemotherapeutic and renal protective effects for the green tea (EGCG): role of oxidative stress and inflammatory-cytokine signaling.
Topics: Animals; Anti-Inflammatory Agents; Antineoplastic Agents, Phytogenic; Antioxidants; C-Reactive Protein; Camellia sinensis; Carcinoma, Ehrlich Tumor; Catechin; Cisplatin; Cytokines; Female; Glomerular Filtration Rate; Kidney; Male; Malondialdehyde; Mice; Oxidative Stress; Phytotherapy; Plant Extracts; Rats; Rats, Sprague-Dawley; Renal Agents; Signal Transduction | 2010 |
The activity against Ehrlich's ascites tumors of doxorubicin contained in self assembled, cell receptor targeted nanoparticle with simultaneous oral delivery of the green tea polyphenol epigallocatechin-3-gallate.
Topics: Administration, Oral; Animals; Antineoplastic Agents; Carcinoma, Ehrlich Tumor; Catechin; Doxorubicin; Magnetic Resonance Spectroscopy; Male; Mice; Microscopy, Electron, Transmission; Nanoparticles; Particle Size; Spectrophotometry, Ultraviolet; Tea | 2013 |
A dosage design of mitomycin C tablets containing finely powdered green tea.
Topics: Animals; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Carcinoma, Ehrlich Tumor; Catechin; Cell Line, Tumor; Drug Combinations; Drug Compounding; Drug Delivery Systems; Hardness; Mitomycin; Powders; Pressure; Tablets; Tea; Time Factors | 2004 |
Novel nucleoside transport inhibitors of natural origin.
Topics: Animals; Antineoplastic Agents; Biological Transport; Carcinoma, Ehrlich Tumor; Catechin; Cell Division; Leukemia L1210; Leukemia, Experimental; Mice; Mice, Inbred DBA; Nucleosides; Phenols; Tea; Tumor Cells, Cultured; Tumor Stem Cell Assay | 1994 |
Screening of anticarcinogenic ingredients in tea polyphenols.
Topics: 3T3 Cells; Animals; Anticarcinogenic Agents; Antimutagenic Agents; Bone Marrow; Carcinoma, Ehrlich Tumor; Catechin; Cell Division; Cell Survival; Cricetinae; Dose-Response Relationship, Drug; Flavonoids; HeLa Cells; Humans; Mice; Mitomycins; Mutagenicity Tests; Phenols; Polymers; Tea; Tumor Cells, Cultured | 1997 |
Involvement of protein tyrosine phosphorylation in the effect of green tea polyphenols on Ehrlich ascites tumor cells in vitro.
Topics: Animals; Anticarcinogenic Agents; Carcinoma, Ehrlich Tumor; Catechin; Cell Survival; Flavonoids; Kinetics; Mice; Neoplasm Proteins; Ornithine Decarboxylase; Phenols; Phosphorylation; Phosphotyrosine; Protein-Tyrosine Kinases; Tea; Tumor Cells, Cultured | 1998 |
Efficacies of tea components on doxorubicin induced antitumor activity and reversal of multidrug resistance.
Topics: Animals; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Caffeine; Calcium Channel Blockers; Carcinoma, Ehrlich Tumor; Catechin; Doxorubicin; Drug Resistance, Multiple; Drug Screening Assays, Antitumor; Drug Synergism; Flavonoids; Glutamates; Intracellular Fluid; Leukemia P388; Male; Mice; Neoplasm Transplantation; Phytotherapy; Tea; Theobromine; Verapamil | 2000 |
Growth inhibitory effect of green tea extract and (-)-epigallocatechin in Ehrlich ascites tumor cells involves a cellular thiol-dependent activation of mitogenic-activated protein kinases.
Topics: Acetylcysteine; Animals; Antineoplastic Agents; Carcinoma, Ehrlich Tumor; Catechin; Cell Division; Cell Survival; Enzyme Activation; Enzyme Inhibitors; Flavonoids; Kinetics; Mice; Mitogen-Activated Protein Kinases; p38 Mitogen-Activated Protein Kinases; Phenols; Phytotherapy; Plant Extracts; Polymers; Sulfhydryl Compounds; Tea; Tumor Cells, Cultured | 2001 |
Cellular thiol status-dependent inhibition of tumor cell growth via modulation of retinoblastoma protein phosphorylation by (-)-epigallocatechin.
Topics: Animals; Carcinoma, Ehrlich Tumor; Catechin; Cell Cycle; Cell Division; Cell Survival; Phosphorylation; Plant Extracts; Retinoblastoma Protein; Sulfhydryl Compounds; Tea; Tumor Cells, Cultured | 2002 |
Rutosides and radiation induced regression of experimental tumours.
Topics: Animals; Carcinoma, Ehrlich Tumor; Catechin; Female; Hydroxyethylrutoside; Iodoacetamide; Male; Mice; Neoplasms, Experimental; Radiation-Protective Agents; Radiation-Sensitizing Agents; Rutin; Sarcoma 180; Uterine Neoplasms | 1977 |
Influence of the flavonoid (+)-catechin on the permeability of Ehrlich mouse ascites tumour cell membranes.
Topics: Adsorption; Animals; Benzopyrans; Carcinoma, Ehrlich Tumor; Catechin; Cell Membrane; Cell Membrane Permeability; Cycloleucine; Diffusion; Female; Mice; Thiourea | 1976 |